Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice
- PMID: 7559464
- DOI: 10.1074/jbc.270.39.23173
Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice
Abstract
p21ras has been implicated in the hypertrophic response of cultured cardiac myocytes to defined growth stimuli. To determine if activation of ras-dependent intracellular signaling pathways is sufficient to induce in vivo hypertrophy, transgenic mice were created that express oncogenic ras in the cardiac ventricular chamber. Mice homozygous for the transgene displayed morphological, physiological, and genetic markers of marked cardiac muscle hypertrophy. Miniaturized catheterization technology documented a selective prolongation of cardiac relaxation, similar to that seen in early human hypertrophic heart disease. An increase in left atrial mass, in the absence of transgene expression in that chamber, further supported physiologically abnormal left ventricular diastolic function. Histological analysis revealed myofibrillar disarray, indistinguishable from that in hypertrophic cardiomyopathy in man. These studies establish a ras-dependent pathway for hypertrophic heart disease and document the feasibility of mapping in vivo signaling pathways for cardiac hypertrophy and dysfunction by applying in vivo microphysiological assays to genetically manipulated mice. ras-dependent pathways may also be a rational target for developing new approaches to inhibit the genesis of hypertrophy in certain pathological settings.
Similar articles
-
Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice.Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4710-5. doi: 10.1073/pnas.94.9.4710. Proc Natl Acad Sci U S A. 1997. PMID: 9114056 Free PMC article.
-
Ras and rho are required for galphaq-induced hypertrophic gene expression in neonatal rat cardiac myocytes.J Mol Cell Cardiol. 1998 Mar;30(3):485-94. doi: 10.1006/jmcc.1997.0613. J Mol Cell Cardiol. 1998. PMID: 9515026
-
Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.Gene. 2014 Feb 25;536(2):225-31. doi: 10.1016/j.gene.2013.12.052. Epub 2013 Dec 27. Gene. 2014. PMID: 24378234
-
Signaling mechanisms for the activation of an embryonic gene program during the hypertrophy of cardiac ventricular muscle.Basic Res Cardiol. 1992;87 Suppl 2:49-58. doi: 10.1007/978-3-642-72477-0_5. Basic Res Cardiol. 1992. PMID: 1299210 Review.
-
Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response.FASEB J. 1991 Dec;5(15):3037-46. doi: 10.1096/fasebj.5.15.1835945. FASEB J. 1991. PMID: 1835945 Review.
Cited by
-
Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA).Am Heart J Plus. 2024 Mar 1;40:100374. doi: 10.1016/j.ahjo.2024.100374. eCollection 2024 Apr. Am Heart J Plus. 2024. PMID: 38510501 Free PMC article.
-
Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.Circ Heart Fail. 2023 Jun;16(6):e010010. doi: 10.1161/CIRCHEARTFAILURE.122.010010. Epub 2023 Jun 12. Circ Heart Fail. 2023. PMID: 37305994 Free PMC article.
-
HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes.Front Cardiovasc Med. 2022 Oct 20;9:948281. doi: 10.3389/fcvm.2022.948281. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36337898 Free PMC article.
-
Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling.Circ Genom Precis Med. 2022 Dec;15(6):e003546. doi: 10.1161/CIRCGEN.121.003546. Epub 2022 Oct 11. Circ Genom Precis Med. 2022. PMID: 36252118 Free PMC article.
-
The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.Int J Mol Sci. 2022 Aug 2;23(15):8582. doi: 10.3390/ijms23158582. Int J Mol Sci. 2022. PMID: 35955714 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous